Table 1.

MID 02-017 Vaccination Schema

Groups for the ECG Analysis	Main Study Groups	Number of Subjects	MVA Dose	Route*	Day 0	Day 28 (Week 4)	Day 112 (Week 16)
1	A	15	2×107	SC	MVA	MVA‡	Dryvax®†
	B	15	5×107	SC	MVA	MVA‡	Dryvax®†
	C	15	1×108	SC	MVA	MVA‡	Dryvax®†
	F	15	1×108	IM	MVA	MVA‡	Dryvax®†
2	D	15	N/A	SC	Placebo**	Placebo**	Dryvax®†
3	E	15	1×108	SC	MVA	MVA‡	Placebo**

^*SC=subcutaneous, IM=intramuscular

^†1 × 10⁸ plaque forming units (pfu)

^‡Tissue culture infective dose 50 (TCID₅₀)

^**The placebo is sterile normal saline